Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of orally administered VX-01 for diabetic retinopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Nonproliferative Diabetic Retinopathy

Drugs mentioned

• VX-01

Snippet

Sponsor: Vantage Biosciences Ltd | Conditions: Diabetic Retinopathy, NPDR - Non Proliferative Diabetic Retinopathy | Phase 2 | Status: RECRUITING